Researcher profile · Semantic Scholar

D. Dixon

h-index: 14
Works: 44
Citations: 1,002

Most-cited papers

Intention to treat in clinical trials
L. Fisher, D. Dixon, J. Herson, R. Frankowski +2 more
1989348 citations
Semantic Scholar
Bayesian subset analysis.
D. Dixon, Richard M. Simon
1991Biometrics145 citations
Semantic Scholar
Sample size considerations for studies comparing survival curves using historical controls.
D. Dixon, Richard Simon
1988Journal of Clinical Epidemiology74 citations
Semantic Scholar
Bayesian methods and ethics in a clinical trial design
D. Dixon
199754 citations
Semantic Scholar
Bayesian subset analysis in a colorectal cancer clinical trial.
D. Dixon, Richard M. Simon
1992Statistics in Medicine54 citations
Semantic Scholar
NIAID Workshop, Memphis, Tennessee, 25-26 March 1997: Statistical issues for HIV surrogate endpoints: Point/counterpoint
J. Albert, J. Ioannidis, P. Reichelderfer, B. Conway +17 more
199837 citations
Semantic Scholar
Strengthening Biostatistics Resources in Sub-Saharan Africa: Research Collaborations through U.S. partnerships
Misrak Gezmu, V. DeGruttola, D. Dixon, M. Essex +7 more
2011Statistics in Medicine34 citations Open access
Semantic Scholar
Statistical issues for HIV surrogate endpoints: point/counterpoint. An NIAID workshop.
J. Albert, John P. A. Ioannidis, P. Reichelderfer, B. Conway +17 more
1998Statistics in Medicine30 citations
Semantic Scholar
HIV vaccine trials: some design issues including sample size calculation.
D. Dixon, Wasima Rida, Patricia E. Fast, Daniel F. Hoth
1993Journal of Acquired Immune Deficiency Syndromes26 citations
Semantic Scholar
Guidelines for data and safety monitoring for clinical trials not requiring traditional data monitoring committees
D. Dixon, R. Freedman, J. Herson, Michael D. Hughes +3 more
2006Clinical Trials24 citations
Semantic Scholar
Should data and safety monitoring boards share confidential interim data?
D. Dixon, Stephen W. Lagakos
2000Controlled Clinical Trials23 citations
Semantic Scholar
Minimum Bayes Risk t-Intervals for Multiple Comparisons
D. Dixon, D. B. Duncan
197521 citations
Semantic Scholar
Issues in regulatory guidelines for data monitoring committees
D. DeMets, R. Califf, D. Dixon, S. Ellenberg +15 more
2004Clinical Trials19 citations Open access
Semantic Scholar
Research benefits for hypothetical HIV vaccine trials: The views of Ugandans in the Rakai District.
C. Grady, Jennifer A. Wagman, R. Ssekubugu, M. Wawer +10 more
2008IRB18 citations
Semantic Scholar
Should Sponsors and DSMBs Share Interim Results Across Trials?
Seema K. Shah, Liza Dawson, D. Dixon, Reidar K. Lie
2011Journal of Acquired Immune Deficiency Syndromes11 citations Open access
Semantic Scholar
Fostering Community Understanding of Sufficient Benefit and Early Stopping for a Phase 2B HIV Prevention Clinical Trial in Africa
Rhonda R. White, Modesta Chileshe, Liza Dawson, Deborah Donnell +4 more
2011Clinical Trials9 citations Open access
Semantic Scholar
Data and safety monitoring policy for National Institute of Allergy and Infectious Diseases clinical trials
D. Dixon, S. Weiss, Kelly Cahill, L. Fox +3 more
2011Clinical Trials9 citations
Semantic Scholar
Relationship between event rates and treatment effects in clinical site differences within multicenter trials: an example from primary Pneumocystis carinii prophylaxis.
John P. A. Ioannidis, D. Dixon, Martin W. McIntosh, J. Albert +2 more
1999Controlled Clinical Trials9 citations
Semantic Scholar
k-ratio t tests for multiple comparisons involving several treatments and a control.
L. Brant, D. B. Duncan, D. Dixon
1992Statistics in Medicine9 citations
Semantic Scholar
Evaluating Protocol Lifecycle Time Intervals in HIV/AIDS Clinical Trials
Scott R. Rosas, J. Schouten, D. Dixon, Suresh Varghese +3 more
2014Clinical Trials7 citations Open access
Semantic Scholar
The Society for Clinical Trials supports United States legislation mandating trials registration
K. Dickersin, Barry R. Davis, D. Dixon, S. George +4 more
2004Clinical Trials6 citations
Semantic Scholar
A Bayesian model for evaluating specificity of treatment effects in clinical trials.
R. Simon, D. Dixon, B. Freidlin
1995Cancer treatment and research6 citations
Semantic Scholar
k‐Ratio t Tests, t Intervals, and Point Estimates for Multiple Comparisons
D. B. Duncan, D. Dixon
20065 citations
Semantic Scholar
Statistical issues in designing clinical trials of aids treatments and vaccines
S. Ellenberg, D. Dixon
19945 citations
Semantic Scholar
Interval Estimates Derived from Bayes Testing Rules
D. Dixon
19765 citations
Semantic Scholar
A bayes solution for the problem of ranking Poisson parameters
D. Dixon, R. P. Bland
19714 citations
Semantic Scholar
Issues in the design and analysis of AIDS clinical trials.
D. Dixon, J. Albert
1995Cancer treatment and research3 citations
Semantic Scholar
Data and Safety Monitoring
L. Friedman, D. Dixon
20122 citations
Semantic Scholar
Treatment‐Covariate Interaction
D. Dixon
20052 citations
Semantic Scholar
Food and Drug Administration guidance on progression-free survival and the intention-to-treat principle
D. Dixon
2015Clinical Trials1 citations
Semantic Scholar
Commentary on Anand et al.
D. Dixon
2011Clinical Trials1 citations
Semantic Scholar
Development and Implementation of Clinical Trial Protocol Templates at the National Institute of Allergy and Infectious Diseases
H. Bridge, M. Smolskis, P. Bianchine, D. Dixon +3 more
2009Clinical Trials1 citations Open access
Semantic Scholar
Prognostic factors and clinical trials.
D. Dixon
1990Oncology1 citations
Semantic Scholar
University of Pennsylvania 10th annual conference on statistical issues in clinical trials: Current issues regarding data and safety monitoring committees in clinical trials (afternoon panel session)
K. Dickersin, D. Dixon, F. Ferris, Judith A. Goldberg +2 more
2018Clinical Trials0 citations
Semantic Scholar
Treatment-Covariate Interaction †
D. Dixon
20140 citations
Semantic Scholar
Commentary on ‘accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimized multi-arm phase I/II trial design’
D. Dixon
2014Trials0 citations Open access
Semantic Scholar
Book Review: Jerry Menikoff and Edward P. Richards 2006: What the Doctor Didn't Say: The Hidden Truth about Medical Research. Oxford University Press. $34.99. ISBN-13 978-0-19-514797-1
D. Dixon
20090 citations
Semantic Scholar
Statistical methods in HIV/AIDS
D. Dixon
2008Statistics in Medicine0 citations Open access
Semantic Scholar
National Institutes of Health (NIH)
J. Ellenberg, D. Dixon
20050 citations
Semantic Scholar
Book Review: Bayesian approaches to clinical trials and health-care evaluation
D. Dixon
20040 citations
Semantic Scholar
Coping with multiple testing.
D. Dixon, G. Pennello
2001Controlled Clinical Trials0 citations
Semantic Scholar
The importance of event rates for clinical site effects in multicenter trials
J. Ioannidis, D. Dixon, Martin W. McIntosh, J. Albert +2 more
19980 citations
Semantic Scholar
Preliminary safety and activity evaluation of new agents for the treatment of HIV-1 infection: Recommended guidelines for trial design
D. Stein, L. Corey, P. Volberding, J. Jermano +11 more
19920 citations
Semantic Scholar
Assessing new cancer treatments: regarding T. M. Morgan's "Analysis of Duration of Response".
D. Dixon
1989Controlled Clinical Trials0 citations
Semantic Scholar

×2

K. Larntz×2

J. Neaton×2

Wasima Rida×2

S. Ellenberg×2